Author

Chi-Yang Chang 1

1 Department Of Internal Medicine, E-Da Hospital/i-Shou Un

ANTIVIRAL TREATMENT AND RISK OF END-STAGE RENAL DISEASE IN PATIENTS WITH HEPATITIS C VIRUS INFECTION

Yao-Chun Hsu, Jaw-Town Lin, Hsiu J. Ho, Chi-Yang Chang, Chun-Ying Wu

DETERMINANTS OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS WITH CIRRHOSIS UNDER CONTINUOUS NUCLEOS(T)IDE ANALOGUES

Yao-Chun Hsu, Chun-Ying Wu, Chi-Yang Chang, Lein-Ray Mo, Jaw-Town Lin

MODIFIED SEQUENTIAL THERAPY CONTAINING LEVOFLOXACIN VERSUS LEVOFLOXACIN TRIPLE THERAPY IN THE SECOND LINE TREATMENT OF HELICOBACTER PYLORI: A RANDOMIZED TRIAL

Jyh-Ming Liou, Jeng-Yih Wu, Chi-Yang Chang, Chieh-Chang Chen, Yu-Jen Fang, Jaw-Town Lin, Ming-Shiang Wu

RISK OF AND PREDICTORS FOR CLINICAL EVENTS FOLLOWING VIROLOGICAL RELAPSE IN CHRONIC HEPATITIS B PATIENTS AFTER CESSATION OF NUCLEOS(T)IDE ANALOGUE THERAPY

Yao-Chun Hsu, Chun-Ying Wu, Chi-Yang Chang, Jaw-Town Lin

SEQUENTIAL THERAPY FOR 10 DAYS VERSUS TRIPLE THERAPY FOR 14 DAYS IN THE FIRST LINE TREATMENT OF HELICOBACTER PYLORI INFECTION- A MULTICENTER, OPEN-LABEL, RANDOMIZED TRIAL

Jyh-Ming Liou, Jaw-Town Lin, Chi-Yang Chang, Jeng-Yih Wu, Wen-Hsiung Chang, Ming-Shiang Wu

Item 1 - 5 / 15
1
2